Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2066 (LINC02066) is a gene that encodes a long non-coding RNA (lncRNA) transcript longer than 200 nucleotides, categorized as a lincRNA (long intergenic non-coding RNA). LINC02066 does not encode a protein but may participate in essential cellular processes such as chromatin remodeling, transcriptional regulation, and modulation of nearby gene expression. Long intergenic non-coding RNAs are a major class of lncRNAs, defined by their location outside of protein-coding regions. While lincRNAs have been shown in some cases to play roles in fine-tuning gene expression, tissue specificity, and sometimes disease, there are currently no experimentally validated functions, disease associations, or drug interactions specifically attributed to LINC02066. Its biological effects, if any, would likely follow general lincRNA principles, such as acting in cis or trans to influence gene regulation, but this has not yet been described for this locus[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2066 (LINC02066).